Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 17, 2011Liver TransplantationOpen Access

Patients With Non–18FFludeoxyglucose-Avid Advanced Hepatocellular Carcinoma on Clinical Staging May Achieve Long-Term Recurrence-Free Survival After Liver Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

AKA. KornbergBKBernadett KüpperATAndrea Tannapfel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kornberg et al. (2011) studied this question.

synapsesocial.com/papers/6a6f204935aa2c282ce08754https://doi.org/10.1002/lt.22416
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy2007 · 203 citations
  2. 2Beyond Milan criteria – chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis2009 · 18 citations
  3. 3Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation2008 · 305 citations
  4. 4Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival2001 · 2,273 citations